Provided by Tiger Trade Technology Pte. Ltd.

AIM ImmunoTech Inc.

1.36
+0.02071.54%
Volume:51.87K
Turnover:70.38K
Market Cap:4.00M
PE:-0.09
High:1.45
Open:1.45
Low:1.31
Close:1.34
52wk High:20.35
52wk Low:1.26
Shares:2.94M
Float Shares:2.65M
Volume Ratio:0.99
T/O Rate:1.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-14.9061
EPS(LYR):-30.9192
ROE:-3138.91%
ROA:-95.42%
PB:-0.66
PE(LYR):-0.04

Loading ...

Bigblu Broadband Announces AIM Delisting and Transition to Private Company

TIPRANKS
·
Nov 19

Ai-Media Technologies Limited (ASX:AIM) About To Shift From Loss To Profit

Simply Wall St.
·
Nov 19

Octopus AIM VCT Reports Half-Yearly Results Amid Market Challenges

TIPRANKS
·
Nov 19

BRIEF-Aim Immunotech Reports Third Quarter 2025 Financial Results And Highlights Continued Progress Across Pipeline With Strategic Focus On Pancreatic Cancer Clinical Program

Reuters
·
Nov 18

AIM ImmunoTech Q3 EPS $(1.57) Misses $(0.98) Estimate, Sales $26.000K Down From $35.000K YoY

Benzinga
·
Nov 18

AIM ImmunoTech reports third quarter results and highlights progress in pancreatic cancer program

Reuters
·
Nov 18

AIM ImmunoTech Reports Third Quarter 2025 Financial Results and Highlights Continued Progress Across Pipeline With Strategic Focus on Pancreatic Cancer Clinical Program

THOMSON REUTERS
·
Nov 18

AIM ImmunoTech Reports Q3 2025 Financial Results

TIPRANKS
·
Nov 18

AIM ImmunoTech Delays Quarterly Financial Report

Reuters
·
Nov 17

Hargreave Hale AIM VCT plc Announces Share Purchase and Cancellation

TIPRANKS
·
Nov 13

Puma AIM VCT PLC Invests in KRM22 Plc

TIPRANKS
·
Nov 12

AIM ImmunoTech Announces Positive Phase 2 Results for Ampligen in Advanced Ovarian Cancer Trial

Reuters
·
Nov 10

AIM ImmunoTech Details New Upmc Abstract on Completed Clinical Trial Involving Ampligen’s Synergistic Potential in the Treatment of Advanced Recurrent Ovarian Cancer

THOMSON REUTERS
·
Nov 10

City execs plot new junior stock exchange to rival AIM

cityam
·
Nov 10

Hargreave Hale AIM VCT 1 Sees Gradual Market Improvement in Q4 2025

TIPRANKS
·
Nov 10

Oberon AIM VCT PLC Extends Share Offer Closing Date

TIPRANKS
·
Nov 07

Pulsar Helium Inc. Announces Stock Option Exercise and AIM Admission

TIPRANKS
·
Nov 07

South Korean Petrochemical Plant Starts Operations in Indonesia

Tempo
·
Nov 06

AIM ImmunoTech Highlights Phase II Study Results for Ampligen in Recurrent Ovarian Cancer at SITC Meeting

Reuters
·
Nov 04

AIM ImmunoTech Granted European Patent for Ampligen® in Long COVID Fatigue Treatment

Reuters
·
Nov 03